Nuveen LLC Acquires Shares of 30,185 Medifast Inc $MED

Key Points

• Nuveen LLC acquired a new stake in MEDIFAST INC, purchasing 30,185 shares worth approximately $407,000, representing about 0.27% of the company.
• Other institutional investors have significantly increased their positions in MEDIFAST, with GAMMA Investing LLC raising its stake by 3,207.2% during the first quarter.
• MEDIFAST reported a better-than-expected earnings per share of $0.04 for the previous quarter, surpassing estimates of ($0.22), with a revenue of $105.56 million.

Nuveen LLC acquired a new position in Medifast Inc (NYSE:MED - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 30,185 shares of the specialty retailer's stock, valued at approximately $407,000. Nuveen LLC owned approximately 0.27% of Medifast at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Benjamin Edwards Inc. increased its stake in shares of Medifast by 75.0% in the first quarter. Benjamin Edwards Inc. now owns 24,419 shares of the specialty retailer's stock worth $329,000 after purchasing an additional 10,469 shares in the last quarter. Charles Schwab Investment Management Inc. increased its stake in shares of Medifast by 132.7% in the first quarter. Charles Schwab Investment Management Inc. now owns 265,572 shares of the specialty retailer's stock worth $3,580,000 after purchasing an additional 151,434 shares in the last quarter. Peapod Lane Capital LLC purchased a new stake in shares of Medifast in the first quarter worth $933,000. Values First Advisors Inc. increased its stake in shares of Medifast by 3.8% in the first quarter. Values First Advisors Inc. now owns 64,228 shares of the specialty retailer's stock worth $869,000 after purchasing an additional 2,340 shares in the last quarter. Finally, SummerHaven Investment Management LLC increased its stake in shares of Medifast by 2.2% in the first quarter. SummerHaven Investment Management LLC now owns 42,073 shares of the specialty retailer's stock worth $567,000 after purchasing an additional 916 shares in the last quarter. 95.51% of the stock is owned by hedge funds and other institutional investors.

Medifast Stock Performance

Shares of NYSE MED traded up $0.03 during midday trading on Tuesday, reaching $13.85. The stock had a trading volume of 68,154 shares, compared to its average volume of 222,257. The stock has a 50-day moving average of $13.97 and a 200-day moving average of $13.62. The company has a market capitalization of $152.21 million, a price-to-earnings ratio of 43.28 and a beta of 0.82. Medifast Inc has a 12-month low of $11.57 and a 12-month high of $21.98.

Medifast (NYSE:MED - Get Free Report) last announced its quarterly earnings data on Monday, August 4th. The specialty retailer reported $0.04 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.22) by $0.26. The firm had revenue of $105.56 million during the quarter, compared to analysts' expectations of $96.10 million. Medifast had a net margin of 0.76% and a return on equity of 2.00%. Medifast has set its Q3 2025 guidance at -0.600-0.00 EPS. As a group, analysts forecast that Medifast Inc will post 0.51 EPS for the current fiscal year.

About Medifast

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.